Browsing by Subject "Oncolytic virus"
Now showing items 1-2 of 2
-
Class I Major Histocompatibility Complex Restricted Epitopes in Oncolytic Virus Infection and Therapy
(2021-08-24)Cancer immunotherapies (re)educate the body’s natural defenses to recognize and attack malignant cells. The consequent anti-tumor immunity is highly specific, long-lasting, and often dependent on CD8 T cells, the presence ... -
REOVIRUS-DRIVEN MYELOID CELLS IN ONCOLYTIC VIRUS THERAPY AND INFECTION
(2018-04-03)Cancer-associated immunosuppression represents a major contributor to tumor progression and impairment of spontaneous or therapeutically-induced anti-tumor immunity. Myeloid cells are a key mediator of such immunosuppression. ...